Sarah Nemec serves as Executive at Bolt Biotherapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Sarah Nemec has executed 2 insider transactions totaling $686, demonstrating a bullish approach to their equity position. Their most recent transaction on Oct 22, 2025 involved receiving (via award) 23,000 shares valued at $0.
Sarah Nemec currently holds 23,943 shares of Bolt Biotherapeutics, Inc. (BOLT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sarah Nemec has been a net buyer of BOLT stock. They have purchased $686 and sold $0 worth of shares.
Sarah Nemec's most recent insider trade was on Oct 22, 2025, when they sold 23,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $5.49 |
| Discretionary |